Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 million.

Google DeepMind’s spin-off Isomorphic Labs says it’s almost ready to begin human testing for AI-designed drugs. Built on the success of AlphaFold, the company aims to speed up drug development in ...

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human?

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI. The news comes ...

The company was spun out of Google DeepMind in 2021, and is built on the breakthrough AlphaFold system, an AI model that stunned the scientific community by accurately predicting ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

A New Era of Research with Health Studio Clinical trials are the backbone of medical advancement but they’ve historically ...

Clinical trials remain the cornerstone of evidence-based medicine, yet they are frequently protracted and costly. More often ...

Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are also racing to use AI in drug discovery.